Innovative Drug Delivery Nanexa's focus on PharmaShell®, a pioneering drug delivery platform, presents opportunities for pharmaceutical companies seeking advanced and customizable delivery solutions for various indications.
Strategic Industry Recognition Being recognized as a finalist in the Drug Delivery Technology category enhances Nanexa's credibility and visibility, creating potential for partnerships with organizations aiming to associate with innovative leaders in drug delivery.
Collaborations & Partnerships Existing collaborations with major industry players like AstraZeneca and partnerships with financial institutions indicate a strong network, offering pathways for future licensing, co-development deals, or joint ventures.
Recent Funding & Development Recent financing of USD 750,000 coupled with ongoing development of compounds such as NEX-20 suggests rapid advancement in technology and pipeline, enabling sales teams to position Nanexa as a promising partner for biotech and pharma innovation projects.
Research & Market Engagement Participation in global conferences like ISPOR Europe and ADA Congress demonstrates active engagement in the health economics and drug development communities, providing channels to connect with decision-makers interested in advanced delivery platforms.
$50M$100M
$100M$250M
$250M$500M
$50M$100M
$1B$10BNanexa AB uses 8 technology products and services including Open Graph, RSS, Microsoft 365, and more. Explore Nanexa AB's tech stack below.
| Nanexa AB Email Formats | Percentage |
| First.Last@nanexa.se | 100% |
| First.Last@nanexa.com | 67% |
| FLast@nanexa.com | 33% |
Pharmaceutical ManufacturingSweden11-50 Employees
Nanexa AB is a drug delivery company that focuses on the development of PharmaShell®, a new and pioneering drug delivery system that is considered to have great potential in a number of substance types and indication areas. Within the framework of PharmaShell®, Nanexa develops its own projects and has collaborative agreements with several pharmaceutical companies, including AstraZeneca.
Company Overview
Funding & FinancialsNanexa AB's revenue is estimated to be in the range of $1M
Funding & FinancialsNanexa AB's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com